May 24, 2024 | The Legal Intelligencer
In the Wake of 'Amgen v. Sanofi,' the USPTO Clarifies the Patent Enablement RequirementThis article provides a brief overview of the Amgen decision and USPTO guidelines, and provides some practical guidance on how one might be able to capture a genus of antibodies in light of these recent developments.
By Travis W. Bliss and Ava E. Lutz
7 minute read
Trending Stories